US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kairos Pharma, Ltd.

0.5990

+0.02905.09%

Volume:552.37K

Turnover:324.21K

Market Cap:10.09M

PE:-2.15

High:0.6190

Open:0.5800

Low:0.5505

Close:0.5700

Loading ...

Overview Company News Filings

Kapa Gold Inc. Announces Successful 2025 AGM Results

Kairos Pharma Enhances U.S. Investor Relations Strategy

Kairos Pharma Ltd. Conducted Investor Relations Meeting

Promising Developments in Oncology Drive Buy Rating for Kairos Pharma

Kairos Pharma Is Maintained at Buy by D. Boral Capital

Kairos Pharma Presents Promising KROS101 Data at ASCO 2025

Kairos Pharma Unveils Promising Data on Cancer Immunotherapy Drug KROS 101 at ASCO 2025 Annual Meeting

Kairos Pharma Ltd. Announces New Data on Small Molecule Gitr Ligand Agonist Kros 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology (Asco) 2025 Annual Meeting

THOMSON REUTERS

Kairos Pharma Q1 EPS $(0.08) Misses $(0.05) Estimate

NYSE American New 52-Week Highs And Lows

NYSE American New 52-Week Highs And Lows

Kairos Pharma Ltd. Announces Change in Certifying Accountants, Dismisses Marcum LLP

Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

BRIEF-Kairos Pharma Remains Financially Strong Despite Recent Economic Headwinds

Kairos Pharma Ltd - Remains Financially Strong Despite Recent Economic Headwinds

THOMSON REUTERS

Kairos Pharma Ltd. Provides Letter to Stockholders

Kairos Pharma files to sell 16.29M shares of common stock for holders

BRIEF-Kairos Pharma Announces Department Of Defense Grant To Support Its Study Of Lead Compound Env105 To Prevent Drug Resistance In Lung Cancer

Kairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound Env105 to Prevent Drug Resistance in Lung Cancer

THOMSON REUTERS

Kairos Pharma Is Maintained at Buy by D. Boral Capital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KAPA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KAPA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAPA\",,,,,undefined,":{"symbol":"KAPA","market":"US","secType":"STK","nameCN":"Kairos Pharma, Ltd.","latestPrice":0.599,"timestamp":1750274937882,"preClose":0.57,"halted":0,"volume":552372,"delay":0,"floatShares":6222871,"shares":16849306,"eps":-0.279234,"marketStatus":"Trading","change":0.029,"latestTime":"06-18 15:29:07 EDT","open":0.58,"high":0.619,"low":0.5505,"amount":324213.8892234,"amplitude":0.120175,"askPrice":0.6,"askSize":10,"bidPrice":0.58,"bidSize":2886,"shortable":3,"etf":0,"ttmEps":-0.279234,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750276800000},"marketStatusCode":2,"adr":0,"listingDate":1717992000000,"exchange":"NASDAQ","adjPreClose":0.57,"preHourTrading":{"tag":"盘前","latestPrice":0.5933,"preClose":0.57,"latestTime":"09:28 EDT","volume":2926,"amount":1715.8207374,"timestamp":1750253302937},"postHourTrading":{"tag":"盘后","latestPrice":0.585,"preClose":0.5749,"latestTime":"19:58 EDT","volume":63659,"amount":37076.98187,"timestamp":1750204700123},"volumeRatio":0.5433},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAPA\",,,,,undefined,":{"symbol":"KAPA","floatShares":6222871,"roa":"-46.61%","roe":"-149.74%","lyrEps":-0.229208,"volumeRatio":0.5433,"shares":16849306,"dividePrice":0,"high":0.619,"amplitude":0.120175,"preClose":0.57,"low":0.5505,"week52Low":0.4,"pbRate":"1.42","week52High":4,"institutionHeld":0,"latestPrice":0.599,"committee":0.993094,"eps":-0.279234,"divideRate":0,"volume":552372,"delay":0,"ttmEps":-0.279234,"open":0.58,"prevYearClose":1.52,"prevWeekClose":0.52,"prevMonthClose":0.61,"prevQuarterClose":0.9362,"fiveDayClose":0.4907,"twentyDayClose":0.59,"sixtyDayClose":0.952},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KAPA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543632565","title":"Kapa Gold Inc. Announces Successful 2025 AGM Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2543632565","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543632565?lang=en_us&edition=fundamental","pubTime":"2025-06-14 03:02","pubTimestamp":1749841338,"startTime":"0","endTime":"0","summary":"KAPA Gold Inc ( ($TSE:KAPA) ) just unveiled an update. Kapa Gold Inc., a Canadian exploration company focused on gold projects in North America, he...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kapa-gold-inc-announces-successful-2025-agm-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kapa-gold-inc-announces-successful-2025-agm-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAPA","AGM","BK4229","BK4139","BK4195","1OZmain"],"gpt_icon":0},{"id":"2543528538","title":"Kairos Pharma Enhances U.S. Investor Relations Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2543528538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543528538?lang=en_us&edition=fundamental","pubTime":"2025-06-13 05:43","pubTimestamp":1749764624,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. ( ($KAPA) ) has provided an announcement. On June 10, 2025, Kairos Pharma, Ltd. entered into a one-year services agreement with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-enhances-u-s-investor-relations-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-enhances-u-s-investor-relations-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4516","BK4596","BK4595","BK4139","BK4588","KAPA","KAIR","STRK","BK4600","BK4023","BK4585"],"gpt_icon":0},{"id":"2543369540","title":"Kairos Pharma Ltd. Conducted Investor Relations Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543369540","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543369540?lang=en_us&edition=fundamental","pubTime":"2025-06-13 05:06","pubTimestamp":1749762364,"startTime":"0","endTime":"0","summary":"Kairos Pharma Ltd. held a meeting on June 10, 2025. Proposals included the election of directors, which was approved. Another proposal related to ratifying the appointment of the company's independent auditors was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kairos Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL6fN7Dl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2541093335","title":"Promising Developments in Oncology Drive Buy Rating for Kairos Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2541093335","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541093335?lang=en_us&edition=fundamental","pubTime":"2025-06-05 01:35","pubTimestamp":1749058512,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Kairos Pharma, Ltd. (KAPA – Research Report), with a pri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-in-oncology-drive-buy-rating-for-kairos-pharma-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-in-oncology-drive-buy-rating-for-kairos-pharma-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAIR","KAPA"],"gpt_icon":0},{"id":"2540653063","title":"Kairos Pharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2540653063","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540653063?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:53","pubTimestamp":1749037980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KAPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 04, 2025 07:53 ET (11:53 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAIR","KAPA"],"gpt_icon":0},{"id":"2540774676","title":"Kairos Pharma Presents Promising KROS101 Data at ASCO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540774676","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540774676?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:45","pubTimestamp":1748954751,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. ( ($KAPA) ) has issued an update. Kairos Pharma Ltd. announced the presentation of new data on its investigational small molecu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-presents-promising-kros101-data-at-asco-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-presents-promising-kros101-data-at-asco-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAPA","KAIR","BK4139"],"gpt_icon":0},{"id":"2540054779","title":"Kairos Pharma Unveils Promising Data on Cancer Immunotherapy Drug KROS 101 at ASCO 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540054779","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540054779?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:15","pubTimestamp":1748952918,"startTime":"0","endTime":"0","summary":"Kairos Pharma Ltd. , a clinical stage biopharmaceutical company, has announced new findings regarding its investigational small molecule GITR ligand agonist, KROS101. Presented at the American Society of Clinical Oncology  2025 Annual Meeting in Chicago, the study highlights KROS101's potential as a cancer immunotherapy. The data indicate that KROS101 exhibits strong activity in enhancing the immune system and targeting tumor cells through its dual mechanism of action. The study demonstrated that KROS101 enhances T cell function by promoting proliferation and increasing cytotoxicity, while also reducing T reg-mediated suppression. The findings suggest that KROS101 is superior to the anti-GITR antibody TRX518 in several aspects, including T cell tumor infiltration and cytotoxicity. The company plans to continue studying KROS101 and engage with the medical and scientific communities regarding these findings.Disclaimer: This news brief was created by Public Technologies  using generative ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL2KTbxy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2540797717","title":"Kairos Pharma Ltd. Announces New Data on Small Molecule Gitr Ligand Agonist Kros 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology (Asco) 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540797717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540797717?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:15","pubTimestamp":1748952900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nTUA7ZV7B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2535718027","title":"Kairos Pharma Q1 EPS $(0.08) Misses $(0.05) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535718027","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535718027?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:33","pubTimestamp":1747229585,"startTime":"0","endTime":"0","summary":"Kairos Pharma (AMEX:KAPA) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.05) by 60 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45406742/kairos-pharma-q1-eps-0-08-misses-0-05-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","KAIR"],"gpt_icon":0},{"id":"2534547274","title":"NYSE American New 52-Week Highs And Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2534547274","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534547274?lang=en_us&edition=fundamental","pubTime":"2025-05-12 22:21","pubTimestamp":1747059660,"startTime":"0","endTime":"0","summary":"COMPANY                      SYMBOL       HIGH         VOLUME. -------                      ------       ----         ------. MAG Silver                   MAG         19.17      3,050,400. COMPANY                      SYMBOL       LOW          VOLUME. -------                      ------       ----         ------. Kairos Pharma                KAPA       0.6200         82,694. Copyright (c) 2025 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","KAIR","KAPA","BK4117","BK4139","AFG","NYSE"],"gpt_icon":0},{"id":"2533314661","title":"NYSE American New 52-Week Highs And Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2533314661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533314661?lang=en_us&edition=fundamental","pubTime":"2025-05-08 22:20","pubTimestamp":1746714000,"startTime":"0","endTime":"0","summary":"COMPANY                      SYMBOL       HIGH         VOLUME. -------                      ------       ----         ------. Aris Mining                  ARMN         6.03        273,244. COMPANY                      SYMBOL       LOW          VOLUME. -------                      ------       ----         ------. Kairos Pharma                KAPA       0.6666         59,121. M-tron Industries Wt         MPTI.WS      1.25          7,832. SRx Health Solutions         SRXH       0.6507         69,383. Theriva Biologics            TOVX       0.6800        642,857. Copyright (c) 2025 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4117","BK4107","BK4139","AFG","KAPA","NYSE","KAIR"],"gpt_icon":0},{"id":"2531293219","title":"Kairos Pharma Ltd. Announces Change in Certifying Accountants, Dismisses Marcum LLP","url":"https://stock-news.laohu8.com/highlight/detail?id=2531293219","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531293219?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:29","pubTimestamp":1745875762,"startTime":"0","endTime":"0","summary":"Kairos Pharma Ltd. has announced a change in its certifying accountants as part of its recent financial reporting update. On April 23, 2025, the company's audit committee appointed Weinberg and Company, P.A. as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. This decision resulted in the dismissal of Marcum LLP, effective on the same date. Marcum's audit reports for the years ended December 31, 2024, and 2023 included no adverse opinions or disclaimers, although the 2023 report noted uncertainty regarding the company's ability to continue as a going concern. There were no disagreements or reportable events with Marcum regarding accounting principles or practices. This transition follows the identification of material weaknesses in internal controls over financial reporting for the fiscal years 2024 and 2023.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nNDL4LKfLx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","CBZ","BK4139","BK4123","LU2065732104.USD"],"gpt_icon":0},{"id":"2530097104","title":"Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2530097104","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530097104?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:00","pubTimestamp":1745841600,"startTime":"0","endTime":"0","summary":"LOS ANGELES, April 28, 2025----Kairos Pharma, Ltd. , a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology  2025 Annual Meeting to be held May 30-June 3, 2025 at McCormick Place, Chicago, Ill.John Yu, M.D., Kairos CEO commented, \"We look forward to the opportunity to continue to share data regarding our platform assets at one of the most prestigious oncology meetings in the world. We believe that KROS 101 has the potential to help optimize cancer treatment and we look forward to discussing our findings with the medical and scientific communities.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kairos-pharma-ltd-announces-data-120000153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AFG","BK4139","KAPA","BK4107","BK4117","KAIR"],"gpt_icon":0},{"id":"2529532981","title":"BRIEF-Kairos Pharma Remains Financially Strong Despite Recent Economic Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2529532981","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529532981?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:21","pubTimestamp":1745497305,"startTime":"0","endTime":"0","summary":"BRIEF-Kairos Pharma Remains Financially Strong Despite Recent Economic HeadwindsApril 24 (Reuters) - Kairos Pharma Ltd KAPA.A:KAIROS PHARMA LTD - REMAINS FINANCIALLY STRONG DESPITE RECENT ECONOMIC HEA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nFWN3R21AK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2529986054","title":"Kairos Pharma Ltd - Remains Financially Strong Despite Recent Economic Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2529986054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529986054?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:11","pubTimestamp":1745496711,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nFWN3R21AK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2529098694","title":"Kairos Pharma Ltd. Provides Letter to Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2529098694","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529098694?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"LOS ANGELES, April 24, 2025----Kairos Pharma, Ltd. , a clinical stage biopharmaceutical company, today provides a letter to stockholders from CEO John Yu, M.D.:. As we reflect on the Company’s progress before and after our initial public offering and listing on the NYSE American stock exchange, I am excited about what the future holds.Despite recent economic headwinds, we remain financially strong due to our recent private placement and judicious use of funds with non-dilutive funding. Thank you for your continued support and confidence in our mission. We look forward to providing you with regular updates on our progress","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kairos-pharma-ltd-provides-letter-120000161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KAPA","KAIR","BK4139"],"gpt_icon":0},{"id":"2529373311","title":"Kairos Pharma files to sell 16.29M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2529373311","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529373311?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:10","pubTimestamp":1745316635,"startTime":"0","endTime":"0","summary":"06:05 EDT Kairos Pharma (KAPA) files to sell 16.29M shares of common stock for holders Published first on TheFly – the ultimate source for real-tim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kairos-pharma-files-to-sell-16-29m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kairos-pharma-files-to-sell-16-29m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KAPA","KAIR"],"gpt_icon":0},{"id":"2528159712","title":"BRIEF-Kairos Pharma Announces Department Of Defense Grant To Support Its Study Of Lead Compound Env105 To Prevent Drug Resistance In Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2528159712","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528159712?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:59","pubTimestamp":1744894750,"startTime":"0","endTime":"0","summary":"BRIEF-Kairos Pharma Announces Department Of Defense Grant To Support Its Study Of Lead Compound Env105 To Prevent Drug Resistance In Lung CancerApril 17 (Reuters) - Kairos Pharma Ltd KAPA.A:KAIROS PHA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA36FRPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"gpt_icon":0},{"id":"2528161167","title":"Kairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound Env105 to Prevent Drug Resistance in Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2528161167","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528161167?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:00","pubTimestamp":1744891204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA36FRPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2528713034","title":"Kairos Pharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2528713034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528713034?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:36","pubTimestamp":1744889760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KAPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 17, 2025 07:36 ET (11:36 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","KAIR"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KAPA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KAPA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KAPA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1743739200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KAPA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KAPA","date":"2025-06-17","current":-2.57116,"percent":0.968085,"low":-25.607053,"twenty":-8.603969,"median":-6.749132,"eighty":-4.767574,"high":-2.140651,"avg":-6.925609,"sd":3.334257,"marketCap":9107049},"quantilePoints":[{"date":"2024-09-13","current":-25.607053,"twenty":-25.607053,"median":-25.607053,"eighty":-25.607053,"marketCap":51367748},{"date":"2024-09-20","current":-14.59602,"twenty":-25.607053,"median":-16.196461,"eighty":-14.724055,"marketCap":29279616},{"date":"2024-09-27","current":-10.594918,"twenty":-16.644584,"median":-14.59602,"eighty":-12.803526,"marketCap":21253405},{"date":"2024-10-04","current":-8.706398,"twenty":-15.748337,"median":-12.835535,"eighty":-9.858715,"marketCap":17465034},{"date":"2024-10-11","current":-9.410592,"twenty":-14.724055,"median":-10.594918,"eighty":-8.706398,"marketCap":18877647},{"date":"2024-10-18","current":-9.410592,"twenty":-14.59602,"median":-9.890724,"eighty":-9.026486,"marketCap":18877647},{"date":"2024-10-25","current":-9.602645,"twenty":-14.019861,"median":-9.73068,"eighty":-9.026486,"marketCap":19262905},{"date":"2024-10-31","current":-8.64238,"twenty":-13.098007,"median":-9.602645,"eighty":-8.947104,"marketCap":17336614},{"date":"2024-11-08","current":-8.770415,"twenty":-12.81633,"median":-9.464686,"eighty":-8.64238,"marketCap":17593453},{"date":"2024-11-15","current":-13.158824,"twenty":-13.152678,"median":-9.474609,"eighty":-8.64238,"marketCap":26396601},{"date":"2024-11-22","current":-7.030345,"twenty":-12.924264,"median":-9.410592,"eighty":-8.578362,"marketCap":19270177},{"date":"2024-11-29","current":-7.217821,"twenty":-12.829133,"median":-9.282556,"eighty":-8.469532,"marketCap":19784048},{"date":"2024-12-06","current":-6.608525,"twenty":-12.265778,"median":-9.026486,"eighty":-7.967725,"marketCap":18113966},{"date":"2024-12-13","current":-8.061463,"twenty":-11.119862,"median":-8.738406,"eighty":-7.667763,"marketCap":22096470},{"date":"2024-12-20","current":-7.920856,"twenty":-10.268428,"median":-8.706398,"eighty":-7.780249,"marketCap":21711066},{"date":"2024-12-27","current":-7.827118,"twenty":-9.999554,"median":-8.64238,"eighty":-7.780249,"marketCap":21454130},{"date":"2025-01-03","current":-7.170953,"twenty":-9.909929,"median":-8.578362,"eighty":-7.46154,"marketCap":19655581},{"date":"2025-01-10","current":-4.827504,"twenty":-9.858715,"median":-8.578362,"eighty":-7.311559,"marketCap":13232188},{"date":"2025-01-17","current":-8.295808,"twenty":-9.858715,"median":-8.530349,"eighty":-7.261949,"marketCap":22738809},{"date":"2025-01-24","current":-7.311559,"twenty":-9.756287,"median":-8.373067,"eighty":-7.264142,"marketCap":20040984},{"date":"2025-01-31","current":-6.936607,"twenty":-9.73068,"median":-8.108332,"eighty":-7.170953,"marketCap":19013241},{"date":"2025-02-07","current":-6.749132,"twenty":-9.628252,"median":-8.036517,"eighty":-7.161579,"marketCap":18499370},{"date":"2025-02-14","current":-6.796001,"twenty":-9.602645,"median":-7.967725,"eighty":-7.030345,"marketCap":18627838},{"date":"2025-02-21","current":-6.233573,"twenty":-9.526207,"median":-7.967725,"eighty":-7.030345,"marketCap":17086224},{"date":"2025-02-28","current":-5.671145,"twenty":-9.474865,"median":-7.897422,"eighty":-6.869431,"marketCap":15544609},{"date":"2025-03-07","current":-5.198227,"twenty":-9.462702,"median":-7.803684,"eighty":-6.730384,"marketCap":14248340},{"date":"2025-03-14","current":-4.773372,"twenty":-9.428261,"median":-7.780249,"eighty":-6.44917,"marketCap":13083812},{"date":"2025-03-21","current":-4.898329,"twenty":-9.410592,"median":-7.639642,"eighty":-6.289816,"marketCap":13426320},{"date":"2025-03-28","current":-4.848346,"twenty":-9.33377,"median":-7.452166,"eighty":-6.092966,"marketCap":13289317},{"date":"2025-04-04","current":-4.698397,"twenty":-9.282556,"median":-7.358428,"eighty":-5.577408,"marketCap":12878307},{"date":"2025-04-11","current":-4.948312,"twenty":-9.244146,"median":-7.311559,"eighty":-5.297393,"marketCap":13563323},{"date":"2025-04-17","current":-4.775903,"twenty":-9.141718,"median":-7.263319,"eighty":-5.121191,"marketCap":12431676},{"date":"2025-04-25","current":-5.470376,"twenty":-9.018804,"median":-7.217821,"eighty":-5.172643,"marketCap":14239390},{"date":"2025-05-02","current":-5.034285,"twenty":-8.912535,"median":-7.170953,"eighty":-5.172643,"marketCap":13104245},{"date":"2025-05-09","current":-4.841892,"twenty":-8.744808,"median":-7.124084,"eighty":-5.140524,"marketCap":12603446},{"date":"2025-05-16","current":-2.898471,"twenty":-8.706398,"median":-7.030345,"eighty":-5.053706,"marketCap":10266383},{"date":"2025-05-23","current":-2.643971,"twenty":-8.706398,"median":-7.030345,"eighty":-4.968305,"marketCap":9364944},{"date":"2025-05-30","current":-2.626341,"twenty":-8.693594,"median":-6.936607,"eighty":-4.902727,"marketCap":9302501},{"date":"2025-06-06","current":-2.390394,"twenty":-8.64238,"median":-6.865004,"eighty":-4.843183,"marketCap":8466776},{"date":"2025-06-13","current":-2.711492,"twenty":-8.629576,"median":-6.796001,"eighty":-4.780395,"marketCap":9604104},{"date":"2025-06-17","current":-2.57116,"twenty":-8.603969,"median":-6.749132,"eighty":-4.767574,"marketCap":9107049}],"updateTime":1750243621568}}}